Ibex Biosciences

Ibex Biosciences

  • Founded: 2015
  • Location: Cumberland, MD
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Therapy area: Malaria
  • Drug types: INF, ONC, NEU
  • Lead product: IBX13
  • Product link: https://www.ibex.bio/pipeline
  • Funding: <10M



job board

Short description:

Biologics, Cell Therapy, Gene Therapy

Drug notes:

Also RD psoriatic arthritis; 22.3 RD sepsis, 2 combo efforts RD oncology; B411 RD oncology; BRLVV RD Parkinson's; P1-DX RD oncology diagnostic

Long description:

Ibex Biosciences is a biotechnology company that is developing therapeutic antibodies, gene therapies, and regenerative medicine programs. Ibex Biosciences is committed to discovering, validating, and developing potential health solutions through investment in unconventional projects and methodologies, irrespective of their recognition within the broader research community. The company has a diverse portfolio of programs, including: Antibodies for the treatment of cancer and autoimmune diseases; Gene therapies for the treatment of inherited diseases and cancer; Regenerative medicine programs for the repair of damaged tissues and organs.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com